Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: J Neuroophthalmol. 2019 Sep;39(3):291–298. doi: 10.1097/WNO.0000000000000786

Figure 2.

Figure 2.

Weekly BCVA assessments for participants with on-chart visual acuity at screening. Graph reflects mean change in the number of ETDRS letters read by participants treated with RPh201 or placebo. A. Mean change in EDTRS letters from baseline for off-chart participants. B. Mean change in EDTRS letters from baseline for on-chart participants. L = baseline; FUP = follow-up after 13 weeks off-drug wash out period (39 weeks).